Thorac Cardiovasc Surg 2018; 66(03): 240-247
DOI: 10.1055/s-0037-1608834
Original Cardiovascular
Georg Thieme Verlag KG Stuttgart · New York

Role of Endovascular Aortic Repair in the Treatment of Infected Aortic Aneurysms Complicated by Aortoenteric or Aortobronchial Fistulae

Chung-Dann Kan
1   Division of Cardiovascular Surgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
,
Hsin-Ling Lee
1   Division of Cardiovascular Surgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
,
Yu-Jen Yang
1   Division of Cardiovascular Surgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
2   Department of Surgery, Kuo General Hospital, Tainan, Taiwan
› Author Affiliations
Further Information

Publication History

29 December 2016

11 October 2017

Publication Date:
05 December 2017 (online)

Abstract

Background The aim of this study was to compare outcomes and identify factors related to increased mortality of open surgical and endovascular aortic repair (EVAR) of primary mycotic aortic aneurysms complicated by aortoenteric fistula (AEF) or aortobronchial fistula (ABF).

Methods Patients with primary mycotic aortic aneurysms complicated by an AEF or ABF treated by open surgery or endovascular repair between January 1993 and January 2014 were retrospectively reviewed. Outcomes were compared between the open surgery and endovascular groups, and a Cox's proportional hazard model was used to determine factors associated with mortality.

Results A total of 29 patients included 14 received open surgery and 15 received endovascular repair. Positive initial bacterial blood culture results included Salmonella spp., oxacillin-resistant Staphylococcus aureus, and Klebsiella pneumoniae. Mortality within 1 month of surgery was higher in the open surgery than in the endovascular group (43 vs. 7%, respectively, p = 0.035). Shock, additional surgery to repair gastrointestinal (GI) or airway pathology, and aneurysm rupture were associated with a higher risk of death. Compared with patients without resection surgery, the adjusted hazard ratio of death within 4 years in patients with resection for GI/bronchial disease was 0.25. Survival within 6 months was better in the endovascular group (p = 0.016).

Conclusion The results of this study showed that EVAR/thoracic EVAR (TEVAR) is feasible for the management of infected aortic aneurysms complicated by an AEF or ABF, and results in good short-term outcomes. However, EVAR/TEVAR did not benefit long-term survival compared with open surgery.

Supplementary Material

 
  • References

  • 1 Müller BT, Wegener OR, Grabitz K, Pillny M, Thomas L, Sandmann W. Mycotic aneurysms of the thoracic and abdominal aorta and iliac arteries: experience with anatomic and extra-anatomic repair in 33 cases. J Vasc Surg 2001; 33 (01) 106-113
  • 2 Oderich GS, Bower TC, Hofer J. , et al. In situ rifampin-soaked grafts with omental coverage and antibiotic suppression are durable with low reinfection rates in patients with aortic graft enteric erosion or fistula. J Vasc Surg 2011; 53 (01) 99-106 , 107.e1–107.e7, discussion 106–107
  • 3 Mosquera VX, Marini M, Pombo-Felipe F. , et al. Predictors of outcome and different management of aortobronchial and aortoesophageal fistulas. J Thorac Cardiovasc Surg 2014; 148 (06) 3020-6.e1 , 2
  • 4 Chiesa R, Melissano G, Marone EM, Kahlberg A, Marrocco-Trischitta MM, Tshomba Y. Endovascular treatment of aortoesophageal and aortobronchial fistulae. J Vasc Surg 2010; 51 (05) 1195-1202
  • 5 Setacci C, de Donato G, Setacci F. Endografts for the treatment of aortic infection. Semin Vasc Surg 2011; 24 (04) 242-249
  • 6 Oliveira N, Bastos Gonçalves F, Ten Raa S. , et al. Do we need long-term follow-up after EVAR and TEVAR or can we simplify surveillance protocols?. J Cardiovasc Surg (Torino) 2014; 55 (02) (Suppl. 01) 151-158
  • 7 Tsai MT, Kan CD. Following the short-term benefit of endovascular repair of mycotic aortic aneurysm: what is the next step?. J Endovasc Ther 2013; 20 (03) 311-314
  • 8 Sörelius K, Mani K, Björck M. , et al; European MAA collaborators. Endovascular treatment of mycotic aortic aneurysms: a European multicenter study. Circulation 2014; 130 (24) 2136-2142
  • 9 Kan CD, Lee HL, Yang YJ. Outcome after endovascular stent graft treatment for mycotic aortic aneurysm: a systematic review. J Vasc Surg 2007; 46 (05) 906-912
  • 10 Kan CD, Lee HL, Luo CY, Yang YJ. The efficacy of aortic stent grafts in the management of mycotic abdominal aortic aneurysm-institute case management with systemic literature comparison. Ann Vasc Surg 2010; 24 (04) 433-440
  • 11 Chaikof EL, Blankensteijn JD, Harris PL. , et al; Ad Hoc Committee for Standardized Reporting Practices in Vascular Surgery of The Society for Vascular Surgery/American Association for Vascular Surgery. Reporting standards for endovascular aortic aneurysm repair. J Vasc Surg 2002; 35 (05) 1048-1060
  • 12 Willie MM. Analysing of Medical Schemes Complaints by Means of Parametric Proportional Hazard Frailty Models. J Public Health Res 2012; 2 (01) 1-7
  • 13 Sedivy P, Spacek M, El Samman K. , et al. Endovascular treatment of infected aortic aneurysms. Eur J Vasc Endovasc Surg 2012; 44 (04) 385-394
  • 14 Dossa CD, Pipinos II, Shepard AD, Ernst CB. Primary aortoenteric fistula: part I. Ann Vasc Surg 1994; 8 (01) 113-120
  • 15 Dossa CD, Pipinos II, Shepard AD, Ernst CB. Primary aortoenteric fistula: part II. Primary aortoesophageal fistula. Ann Vasc Surg 1994; 8 (02) 207-211
  • 16 Picichè M, De Paulis R, Fabbri A, Chiariello L. Postoperative aortic fistulas into the airways: etiology, pathogenesis, presentation, diagnosis, and management. Ann Thorac Surg 2003; 75 (06) 1998-2006
  • 17 Bogey Jr WM, Thomas JH, Hermreck AS. Aortoesophageal fistula: report of a successfully managed case and review of the literature. J Vasc Surg 1992; 16 (01) 90-95
  • 18 Jia X, Dong YF, Liu XP, Xiong J, Zhang HP, Guo W. Open and endovascular repair of primary mycotic aortic aneurysms: a 10-year single-center experience. J Endovasc Ther 2013; 20 (03) 305-310
  • 19 Kan CD, Yen HT, Kan CB, Yang YJ. The feasibility of endovascular aortic repair strategy in treating infected aortic aneurysms. J Vasc Surg 2012; 55 (01) 55-60
  • 20 Oliva VL, Bui BT, Leclerc G. , et al. Aortoesophageal fistula: repair with transluminal placement of a thoracic aortic stent-graft. J Vasc Interv Radiol 1997; 8 (1 Pt 1): 35-38
  • 21 Deshpande A, Lovelock M, Mossop P, Denton M, Vidovich J, Gurry J. Endovascular repair of an aortoenteric fistula in a high-risk patient. J Endovasc Surg 1999; 6 (04) 379-384
  • 22 Moulakakis KG, Sfyroeras GS, Mylonas SN. , et al. Outcome after preservation of infected abdominal aortic endografts. J Endovasc Ther 2014; 21 (03) 448-455
  • 23 Capoccia L, Mestres G, Riambau V. Current technology for the treatment of infection following abdominal aortic aneurysm (AAA) fixation by endovascular repair (EVAR). J Cardiovasc Surg (Torino) 2014; 55 (03) 381-389
  • 24 Fatima J, Duncan AA, de Grandis E. , et al. Treatment strategies and outcomes in patients with infected aortic endografts. J Vasc Surg 2013; 58 (02) 371-379
  • 25 Lew WK, Rowe VL, Cunningham MJ, Weaver FA. Endovascular management of mycotic aortic aneurysms and associated aortoaerodigestive fistulas. Ann Vasc Surg 2009; 23 (01) 81-89
  • 26 Bailey CJ, Force S, Milner R, Kasirajan K, Veeraswamy RK. Thoracic endovascular repair as a safe management strategy for aortobronchial fistulas. J Vasc Surg 2011; 53 (05) 1202-1209 , discussion 1209
  • 27 Jonker FH, Schlösser FJ, Moll FL. , et al. Outcomes of thoracic endovascular aortic repair for aortobronchial and aortoesophageal fistulas. J Endovasc Ther 2009; 16 (04) 428-440
  • 28 Verhoeven EL, Vourliotakis G. Thoracic endovascular aortic repair for aortobronchial or aortoesophageal fistulas: permanent or temporary salvage or not an option at all?. J Endovasc Ther 2009; 16 (04) 441-442